The NASS Podcast

Featuring: F. Todd Wetzel, MD, John Ney, MD, Tara Stewart, PhD, DABNM Disclosures: Wetzel, F. Todd: Stock Ownership: Relievant Medical (1%).  Ney, John: Board of Directors: American Society for Neuromonitoring (None); Consulting: Ceribell (B), SpecialtyCare (B); Other Office: American Academy of Neurology, Medical Economics and Management Committee (Travel Expense Reimbursement); Speaking and...

Featuring: Scott Blumenthal, MD, Richard D. Guyer, MD, Jack E. Zigler, MD Disclosures: Blumenthal, Scott: Royalties: Aesculap (A); Stock Ownership: FzioMed (1%), VertiFlex (1%), Centinel Spine (1%); Consulting: Sites Medical (None), Aesculap (C), Vertera (None), Bayliss Medical (C), Orthofix (None); Speaking and/or Teaching Arrangements: Aesculap (D), VertiFlex (B), Bayliss (None); Scientific Advi...

Featuring: F. Todd Wetzel, MD, Chris J. Main, MA, PhD, Gregory L. Whitcomb, DC Disclosures: Wetzel, F. Todd: Stock Ownership: Relievant Medical (1%).  Main, Chris J.: Consulting: Medrisk Inc International Scientific Advisory Board (B, Paid directly to institution/employer); Device or Biologic Distribution Group (Physician-Owned Distributorship): The Back Book (B).  Whitcomb, Gregory L.:...

Featuring: Scott Blumenthal, MD, Richard D. Guyer, MD, Jack E. Zigler, MD Disclosures: Blumenthal, Scott: Royalties: Aesculap (A); Stock Ownership: FzioMed (1%), VertiFlex (1%), Centinel Spine (1%); Consulting: Sites Medical (None), Aesculap (C), Vertera (None), Bayliss Medical (C), Orthofix (None); Speaking and/or Teaching Arrangements: Aesculap (D), VertiFlex (B), Bayliss (None); Scientific Advi...

[12 of 12] Section on Intraoperative Neurophysiological Monitoring (IONM) Section Co-Chairs Dr. Rich Vogel and Dr. Adam Doan discuss the question, “ Are wakeups always prolonged with neuromonitoring under TIVA?” It’s a common complaint: we use TIVA for MEPs, but the patients take forever to wake up from anesthesia. To combat this problem, many surgeons elect to discontinue IONM earlier in the proc...

[3 of 3] In this newest episode from the Section on Spine Oncology , Drs. Schwab, Sciubba, and Goodwin discuss operating on neurofibromas.  Surgery on patients with neurofibromas can range from relatively straightforward (simple neurofibromas) to life-threatening (complex plexiform neurofibromas).  In patients with plexiform neurofibromas, particularly those near the spinal cord, care ne...

[11 of 12] Section on Intraoperative Neurophysiological Monitoring (IONM) Section Co-Chairs Dr. Rich Vogel and Dr. Adam Doan discuss the question, “ Neuromonitoring lost their signals, now what?” Aside from checking wires and anesthesia, what else works? It turns out there is a lot one can do to restore signals. Here the Co-Chairs review these checks and interventions. Disclosures: Doan, Adam: Pri...

[10 of 12] Section on Intraoperative Neurophysiological Monitoring (IONM) Section Co-Chairs Dr. Rich Vogel and Dr. Adam Doan discuss, " Diagnostic accuracy of IONM from the neurophysiologist’s perspective." They review the traditional diagnostic table (i.e., ± alert, ± deficit) and consider other factors like intervention, resolution of data, type of monitoring modality, etc. They also present an...

[2 of 3] In this podcast, Matthew Goodwin, MD, PhD, of Washington University Orthopaedics/Barnes-Jewish and the Washington University Spine Tumor Center and Section on Spine Oncology Chair, discusses the question often asked of spine surgeons by other services, "Why do you need an X-ray when we have a CT, MRI, etc?"   Hear him address this question with a few short case examples, five of the...

Featuring: Zorica Buser, PhD, Mark Erwin, DC, PhD Disclosures: Buser, Zorica: Consulting: AOSpine (B), Xenco Medical (B); Research Support (Investigator Salary): SeaSpine (F, Paid directly to institution/employer); Research Support (Staff and/or materials): SeaSpine (F, Paid directly to institution/employer); Trips/Travel: AOSpine (Travel Expense Reimbursement). Erwin, William Mark: Board of Direc...

Featuring: Christina L. Goldstein, MD, FRCSC, Scott D. Daffner, MD, Gregory D. Schroeder, MD Disclosures: Daffner, Scott D.: Consulting: Bioventus (B); Fellowship Support: AO Spine (E, Paid directly to institution/employer),  Medtronic (D, Outside 12-Month Requirement, Paid directly to institution/employer); Grants: AO Foundation (F, Outside 12-Month Requirement, Paid directly to institution/...

[9 of 12] Section on Intraoperative Neurophysiological Monitoring (IONM) Section Co-Chairs Dr. Rich Vogel and Dr. Adam Doan discuss the question, “Is it really an alert? Whence the criteria?” The criteria for calling an alert in IONM have evolved over the years and many people don’t know what the latest research says. This causes a lot of false positives (and some false negatives). We review what...

Featuring: Evan K. Johnson, PT, DPT, OCS, Rick J. Placide, MD, PT Disclosures: Johnson, Evan K.: Nothing to Disclose   Placide, Rick J.: Nothing to Disclose   Key: A: $100-$1,000; B: $1001-$10,000; C: $10,001-$25,000; D: $25,001-$50,000; E: $50,001-$100,000; F: $100,001- $500,000; G: $500,001-$1M; H: $1,000,001- $2.5M; I: $2.5M+

[1 of 3] Hosted by Joseph H. Schwab, MD and Matthew L. Goodwin, MD, PhD, this episode by the Section on Spine Oncology discusses the question, "Why do we want to be concerned about systemic disease and predict survival?" The hosts review the concept of predictive modeling for spinal metastases and include discussion on NOMs and SINs criteria, reviewing the strengths and weaknesses of each and fini...

[8 of 12] Section on Intraoperative Neurophysiological Monitoring (IONM) Section Co-Chairs Dr. Rich Vogel and Dr. Adam Doan discuss the question, “What can you do to improve accuracy of pedicle screw stimulation?” Pedicle screw stimulation was developed and tested under very specific methods, but very few people follow these methods, and this reduces the accuracy. We return to the basics and make...

Featuring: Michael G. Fehlings, MD, PhD, FRCSC, Paul M. Arnold, MD Disclosures: Arnold, Paul M.: Board of Directors: AANS/CNS Joint Section on Neurotrauma (Nonfinancial), CSRS (Nonfinancial), LSRS (Nonfinancial), SpineEx (1%); Consulting: Asterias (A, Outside 12-Month Requirement), Cerapedics (C), Medtronic (B), Spine Wave (B); Research Support (Staff and/or materials): Evoke Medical, LLC (40%, Pa...

[7 of 12] Section on Intraoperative Neurophysiological Monitoring (IONM) Co-Chairs Dr. Rich Vogel and Dr. Adam Doan discuss the question, “Are there any real contraindications to MEPs?” This episode, the Co-Chairs cut through the common myths associated with MEP contraindications: there are no absolute contraindications and all of the relative contraindications have actually been shown to be quite...

Featuring: Michael Y. Wang, MD, Michael P. Steinmetz, MD Disclosures: Steinmetz, Michael P.: Royalties: Biomet Spine (B); Consulting: Intellirod (A), Stryker Spine (B), Globus (B); Speaking and/or Teaching Arrangements: Stryker (B); Board of Directors: AANS/CNS Section on Disorders of the Spine (Chair Exhibits Committee), Council of State Neurosurgical Societies (Vice Chair); Scientific Advisory B...

[6 of 12] Section on Intraoperative Neurophysiological Monitoring (IONM) Co-Chairs Dr. Rich Vogel and Dr. Adam Doan discuss the question, “How can you use neuromonitoring to guide and optimize positioning for spine surgery?” The patient is finally in position and neuromonitoring can’t get baselines. What do you do? If you elect to intervene, it’s a long process to retest baselines in a neutral pos...

Featuring: Peter Witt, MD, Michael Y. Wang, MD Disclosures: Wang, Michael Y.: Royalties: DePuy Synthes Spine (F); Stock Ownership: ISD (<1%), Medical Device Partners (<1%); Consulting: Stryker (C), Spineology (C), K2M (C), DePuy Synthes (C); Scientific Advisory Board: Vallum (A). Witt, Peter: Nothing to Disclose Key: A: $100-$1,000; B: $1001-$10,000; C: $10,001-$25,000; D: $25,001-$50,000; E...

Featuring: Mark M. Mikhael, MD, Christopher F. Wolf, MD, Nick Shamie, MD, Lisa A. Ferrara, PhD Disclosures: Ferrara, Lisa A.: Consulting: OrthoKinetic Technologies (Salary, Paid directly to institution/employer); Scientific Advisory Board: 4Web (less than 1%), Diamond Orthopedics (Salary, Paid directly to institution/employer). Mikhael, Mark M.: Consulting: Clariance Spine (B), GS Medical (B). Sha...

Featuring: Nathaniel P. Brooks, MD, Khoi D. Than, MD, Michael P. Steinmetz, MD Disclosures: Brooks, Nathaniel P.: Other: NASS (Minimally Invasive Procedure Section Chair). Than, Khoi Duc: Consulting: Bioventus (B), Medtronic (A). Steinmetz, Michael P.: Royalties: Biomet Spine (B); Consulting: Intellirod (A), Stryker Spine (B), Globus (B); Speaking and/or Teaching Arrangements: Stryker (B); Bo...

Featuring: Ronald G. Donelson, MD, MS, Ryan A. Tauzell, PT, MA, MDT, F. Todd Wetzel, MD Disclosures: Donelson, Ronald G.: Scientific Advisory Board: Chord Health Inc. (A); Stock Ownership: Chord Health Inc (A, 4%). Tauzell, Ryan A.: Other: North American Spine Society (Travel Expense Reimbursement). Wetzel, F. Todd: Stock Ownership: Relievant Medical (less than 1%). Key: A: $100-$1,000; B: $1001-$...

Moderator Chad Patton, MD, interviews SpineLine authors Sarah C. Rispinto, PhD and Kush Goyal, MD, to discuss their article, “A Biopsychosocial Approach in the Management of Chronic Low Back Pain in a Large Hospital System: Program Feasibility and Initial Outcomes.”  The article first appeared in the July/August 2018 edition of SpineLine .  Access the article here .  Disclosures: Go...

Featuring: Ronald G. Donelson, MD, MS, Ryan Tauzell, PT, MA, MDT, F. Todd Wetzel, MD Disclosures: Donelson, Ronald G.: Scientific Advisory Board: Chord Health Inc. (A); Stock Ownership: Chord Health Inc (A, 4%). Tauzell, Ryan A.: Other: North American Spine Society (Travel Expense Reimbursement). Wetzel, F. Todd: Stock Ownership: Relievant Medical (less than 1%). Key: A: $100-$1,000; B: $1001-$10,...